Sponsor Pipeline

Monte Rosa Therapeutics, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
5
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-04 NCT07745361 Study of Oral MRT-2359 With Apalutamide in Prostate Cancer Phase 2 Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07745361 Study of Oral MRT-2359 With Apalutamide in Prostate Cancer Castration-Resistant Prostate Cancer (CRPC) Recruiting
Phase 1/2
NCT05546268 Study of Oral MRT-2359 in Selected Cancer Patients NSCLC Active, Not Recruiting
Phase 1
NCT07119125 A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at… Healthy Volunteers Active, Not Recruiting
Disease Areas
Prostate Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1) Breast Cancer (1) DLBCL (1)
Get alerts when Monte Rosa Therapeutics, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free